{"id":3020,"date":"2023-10-19T14:03:39","date_gmt":"2023-10-19T18:03:39","guid":{"rendered":"https:\/\/www.openx.com\/?post_type=case-studies&p=3020"},"modified":"2023-10-20T13:32:41","modified_gmt":"2023-10-20T17:32:41","slug":"a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx","status":"publish","type":"case-studies","link":"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/","title":{"rendered":"A Global Pharmaceutical Brand Achieved 89% Viewability, 27% Above Their Target, While Maintaining CPM Efficiency With Supply-Side Targeted Deals From OpenX"},"content":{"rendered":"","protected":false},"author":2,"featured_media":3021,"template":"","format":"standard","categories":[],"tags":[],"acf":[],"yoast_head":"\nA Global Pharmaceutical Brand Achieved 89% Viewability, 27% Above Their Target, While Maintaining CPM Efficiency With Supply-Side Targeted Deals From OpenX | OpenX<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Global Pharmaceutical Brand Achieved 89% Viewability, 27% Above Their Target, While Maintaining CPM Efficiency With Supply-Side Targeted Deals From OpenX | OpenX\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/\" \/>\n<meta property=\"og:site_name\" content=\"OpenX\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OpenX\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-20T17:32:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.openx.com\/wp-content\/uploads\/2023\/09\/hero-case-global-pharmaceutical.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"994\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@OpenX\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/\",\"url\":\"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/\",\"name\":\"A Global Pharmaceutical Brand Achieved 89% Viewability, 27% Above Their Target, While Maintaining CPM Efficiency With Supply-Side Targeted Deals From OpenX | OpenX\",\"isPartOf\":{\"@id\":\"https:\/\/www.openx.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.openx.com\/wp-content\/uploads\/2023\/09\/hero-case-global-pharmaceutical.jpg\",\"datePublished\":\"2023-10-19T18:03:39+00:00\",\"dateModified\":\"2023-10-20T17:32:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/#primaryimage\",\"url\":\"https:\/\/www.openx.com\/wp-content\/uploads\/2023\/09\/hero-case-global-pharmaceutical.jpg\",\"contentUrl\":\"https:\/\/www.openx.com\/wp-content\/uploads\/2023\/09\/hero-case-global-pharmaceutical.jpg\",\"width\":2000,\"height\":994},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.openx.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Case Studies\",\"item\":\"https:\/\/www.openx.com\/case-studies\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"A Global Pharmaceutical Brand Achieved 89% Viewability, 27% Above Their Target, While Maintaining CPM Efficiency With Supply-Side Targeted Deals From OpenX\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.openx.com\/#website\",\"url\":\"https:\/\/www.openx.com\/\",\"name\":\"OpenX\",\"description\":\"Industry-leading technology, premium service, and huge scale make us the world's most dynamic exchange for data and identity \u2014 whether cookies are here or not.\",\"publisher\":{\"@id\":\"https:\/\/www.openx.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.openx.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.openx.com\/#organization\",\"name\":\"OpenX\",\"url\":\"https:\/\/www.openx.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.openx.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.openx.com\/wp-content\/uploads\/2021\/09\/logo-openx.png\",\"contentUrl\":\"https:\/\/www.openx.com\/wp-content\/uploads\/2021\/09\/logo-openx.png\",\"width\":1200,\"height\":628,\"caption\":\"OpenX\"},\"image\":{\"@id\":\"https:\/\/www.openx.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/OpenX\/\",\"https:\/\/x.com\/OpenX\",\"https:\/\/www.instagram.com\/openxlife\/\",\"https:\/\/www.linkedin.com\/company\/openx\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Global Pharmaceutical Brand Achieved 89% Viewability, 27% Above Their Target, While Maintaining CPM Efficiency With Supply-Side Targeted Deals From OpenX | OpenX","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/","og_locale":"en_US","og_type":"article","og_title":"A Global Pharmaceutical Brand Achieved 89% Viewability, 27% Above Their Target, While Maintaining CPM Efficiency With Supply-Side Targeted Deals From OpenX | OpenX","og_url":"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/","og_site_name":"OpenX","article_publisher":"https:\/\/www.facebook.com\/OpenX\/","article_modified_time":"2023-10-20T17:32:41+00:00","og_image":[{"width":2000,"height":994,"url":"https:\/\/www.openx.com\/wp-content\/uploads\/2023\/09\/hero-case-global-pharmaceutical.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@OpenX","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/","url":"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/","name":"A Global Pharmaceutical Brand Achieved 89% Viewability, 27% Above Their Target, While Maintaining CPM Efficiency With Supply-Side Targeted Deals From OpenX | OpenX","isPartOf":{"@id":"https:\/\/www.openx.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/#primaryimage"},"image":{"@id":"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/#primaryimage"},"thumbnailUrl":"https:\/\/www.openx.com\/wp-content\/uploads\/2023\/09\/hero-case-global-pharmaceutical.jpg","datePublished":"2023-10-19T18:03:39+00:00","dateModified":"2023-10-20T17:32:41+00:00","breadcrumb":{"@id":"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/#primaryimage","url":"https:\/\/www.openx.com\/wp-content\/uploads\/2023\/09\/hero-case-global-pharmaceutical.jpg","contentUrl":"https:\/\/www.openx.com\/wp-content\/uploads\/2023\/09\/hero-case-global-pharmaceutical.jpg","width":2000,"height":994},{"@type":"BreadcrumbList","@id":"https:\/\/www.openx.com\/case-studies\/a-global-pharmaceutical-brand-achieved-89-viewability-27-above-their-target-while-maintaining-cpm-efficiency-with-supply-side-targeted-deals-from-openx\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.openx.com\/"},{"@type":"ListItem","position":2,"name":"Case Studies","item":"https:\/\/www.openx.com\/case-studies\/"},{"@type":"ListItem","position":3,"name":"A Global Pharmaceutical Brand Achieved 89% Viewability, 27% Above Their Target, While Maintaining CPM Efficiency With Supply-Side Targeted Deals From OpenX"}]},{"@type":"WebSite","@id":"https:\/\/www.openx.com\/#website","url":"https:\/\/www.openx.com\/","name":"OpenX","description":"Industry-leading technology, premium service, and huge scale make us the world's most dynamic exchange for data and identity \u2014 whether cookies are here or not.","publisher":{"@id":"https:\/\/www.openx.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.openx.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.openx.com\/#organization","name":"OpenX","url":"https:\/\/www.openx.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.openx.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.openx.com\/wp-content\/uploads\/2021\/09\/logo-openx.png","contentUrl":"https:\/\/www.openx.com\/wp-content\/uploads\/2021\/09\/logo-openx.png","width":1200,"height":628,"caption":"OpenX"},"image":{"@id":"https:\/\/www.openx.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OpenX\/","https:\/\/x.com\/OpenX","https:\/\/www.instagram.com\/openxlife\/","https:\/\/www.linkedin.com\/company\/openx\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.openx.com\/wp-json\/wp\/v2\/case-studies\/3020"}],"collection":[{"href":"https:\/\/www.openx.com\/wp-json\/wp\/v2\/case-studies"}],"about":[{"href":"https:\/\/www.openx.com\/wp-json\/wp\/v2\/types\/case-studies"}],"author":[{"embeddable":true,"href":"https:\/\/www.openx.com\/wp-json\/wp\/v2\/users\/2"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.openx.com\/wp-json\/wp\/v2\/media\/3021"}],"wp:attachment":[{"href":"https:\/\/www.openx.com\/wp-json\/wp\/v2\/media?parent=3020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.openx.com\/wp-json\/wp\/v2\/categories?post=3020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.openx.com\/wp-json\/wp\/v2\/tags?post=3020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}